Hyperphosphatemic tumoral calcinosis is a disorder of phosphate regulation caused due to a defect in the functioning of fibroblast growth factor-23 and inherited in an autosomal recessive manner in the vast majority of patients. It manifests as increased serum phosphate levels resulting in the formation of ectopic calcific masses in peri-articular locations and occasional inflammatory bony pains. The management is based on the description of previous case series and case reports and involves phosphate-lowering therapies, anti-inflammatory medications, and sometimes surgical management in severely disabling patients. This activity reviews the evaluation and management of hyperphosphatemic tumoral calcinosis and highlights the role of the interprofessional team in evaluating and managing patients with this condition.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/135520
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABOS - 1.0 Point; Credit Type(s): Accredited CME (ABOS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Orthopaedics, General Surgery, Internal Medicine, Soft Tissue & Bone